yl23455永利
中
/
EN
Home
About Us
Corporate Overview
Founders
Subsidiary Company
Honor
Partnership
Partnership
Partner
Scientific Research
Pipeline
Publications
News
Company News
Media Information
Investor Relations
Careers
Contact Us
Home
About Us
Corporate Overview
Founders
Subsidiary Company
Honor
Strategic Cooperation
Partnership
Partner
Scientific Research
Pipeline
Publications
News
Company News
Media Information
Investor Relations
Careers
Contact Us
CN
EN
About Us
Shenogen Pharma GroupShenogen Pharma Group is a drug discovery and development company founded in 2006 at Beijing, China. Shenogen aims to dev…
News
Beijing Shenogen Pharma Group Ltd. Disclosed the New Findings Related to Icaritin treatment induced Immunomodulation in HCC Tumor Microenvironment
2020
09.25
Cancer Science Online Publication: Phase II Data Demonstrated Clinical Safety and Efficacy of First-in-Class Small Molecule Icaritin in Patients with Advanced HBV-related Hepatocellular Carcinoma
2019
04.12
icaritin phase IIA trial showed favorable safety profiles and preliminary durable survival benefits in advanced HCC patients in BMC Cancer online Publication
Scientific Committee
Pipeline Products
XML地图
